3ZL-22069-03969

2 vaccinations 9 coded responses 16 check-ins 9 free-text entries 4 call cases

Sex: Female
Age at first dose: 46-50
ZIP prefix: 937 / CA
Registered: 2021-01-13

Relationship: Self
Race: N/A
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-13
Registered in v-safe
2021-01-13
Dose 1 — Pfizer-BioNTech
2021-01-13
Survey response — day 0, dose 1
MedDRA: Musculoskeletal stiffness — Feeling: Good · Headache

Free text: Stiff neck

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site hypoaesthesia, Injection site pain — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Burning and numbing sensation at injection site, and its surrounding tissues, involving biceps and deltoid.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 1
MedDRA: Burning sensation, Disorientation, Dizziness, Eye irritation, Lacrimation increased, Respiratory tract congestion, Swelling — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activities

Free text: Sever congestion, dizzy, disoriented, eyes tearing and burning, swelling, all over my body burning

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache · Be unable to do your normal daily activities

Adult check-in
2021-01-17
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-19
Survey response — days 1–6 daily, dose 1
MedDRA: Sinusitis — Feeling: Good · Headache

Free text: Symptoms Similar to sinus infection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-22
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-27
Survey response — day 14, dose 1
MedDRA: Pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Body ache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-03
Dose 2 — Pfizer-BioNTech
2021-02-11
Survey response — day 7, dose 2
MedDRA: Injection site reaction, Mobility decreased — Feeling: Poor · Site: Itching · Headache · Be unable to work

Free text: Limp Muscle at injection site. Could not raise my arm for 5 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-17
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-07
Survey response — 3 months, dose 2
MedDRA: Headache — Feeling: Good · Be unable to work

Free text: Headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-04
Survey response — 6 months, dose 2
MedDRA: Depression — Feeling: Fair · Be unable to do your normal daily activities

Free text: Depression

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-02-03
Survey response — 12 months, dose 2
MedDRA: Brain fog, Disorientation, Headache, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: 15 days of excruciating headache. I was extremely foggy and disoriented. · Healthcare visit (other): I was so affected, it was hard for me to seek more help or go get tested

MedDRA releases: 2024-11 · check-in free text available
2022-02-03
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-04
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-13	Pfizer-BioNTech
2	2021-02-03	Pfizer-BioNTech

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 0, dose 1

2021-01-13

Systemic reaction (other): Stiff neck

Release 2 — days 1–6 daily, dose 1

2021-01-14

Systemic reaction (other): Burning and numbing sensation at injection site, and its surrounding tissues, involving biceps and deltoid.

2021-01-15

Systemic reaction (other): Sever congestion, dizzy, disoriented, eyes tearing and burning, swelling, all over my body burning

2021-01-19

Systemic reaction (other): Symptoms Similar to sinus infection

Release 2 — day 14, dose 1

2021-01-27

Symptoms: Body ache

Release 4 — day 7, dose 2

2021-02-11

Systemic reaction (other): Limp Muscle at injection site. Could not raise my arm for 5 days.

Release 8 — 3 months, dose 2

2021-05-07

Symptoms: Headache

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: Depression

Release 11 — 12 months, dose 2

2022-02-03

Symptoms: 15 days of excruciating headache. I was extremely foggy and disoriented.

Healthcare visit (other): I was so affected, it was hard for me to seek more help or go get tested

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Brain fog	·	·	✓
SD	Depression	✓	·	✓
SD	Disorientation	·	·	✓
SD	Headache	✓	✓	✓
SD	Pain	✓	✓	✓
SRO	Burning sensation	✓	✓	✓
SRO	Disorientation	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Eye irritation	✓	✓	✓
SRO	Injection site hypoaesthesia	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Injection site reaction	✓	✓	✓
SRO	Lacrimation increased	✓	✓	✓
SRO	Mobility decreased	✓	✓	✓
SRO	Musculoskeletal stiffness	✓	✓	✓
SRO	Respiratory tract congestion	✓	✓	✓
SRO	Sinusitis	✓	✓	✓
SRO	Swelling	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release